Patent · US Active

Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide

US9212129B2 · kind B2 · utility

4Cited by
1References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 17, 2013
Grant dateDec 15, 2015
Priority date—
Expiry dateMay 17, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Isolated metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]-methyl]propanamide, methods for their use, and compositions containing the metabolites.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.